AIG

AIG SALE OF NAN SHAN DELAYED BY TAIWAN PROBE INTO CHINA LINK

The proposed $2.2bn purchase of AIG's Taiwan insurance unit by a Hong Kong consortium is facing scrutiny amid regulatory concerns that include whether the buyers are backed by Chinese funds.

AIG agreed in October to sell Nan Shan, Taiwan's second-largest life insurer, to a consortium led by Primus Financial, a financial services fund, but the probe has delayed approval.

The largest member of the consortium is China Strategic, a Hong Kong-listed battery maker whose new business focus is financial services.

您已閱讀28%(508字),剩餘72%(1337字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×